Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bioventus Inc.BVS · Entity 4996 | Director | June 02, 2026 | June 04, 2026 |
| Inogen IncINGN · Entity 2083 | Director | June 05, 2026 | June 09, 2026 |
| KESTRA MEDICAL TECHNOLOGIES, LTD.KMTS · Entity 4686 | Director | September 08, 2026 | September 11, 2026 |
| NOVANTA INCNOVT · Entity 3857 | Director | January 02, 2026 | January 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bioventus Inc.
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 111,263 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Exercise / conversion · Acquired 32,282 · Balance 111,263 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-02 · Exercise / conversion · Disposed 32,282 · Balance 0 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F2: The RSUs vested on June 2, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 25,146 |
Reported balance
After 2026-06-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-03 · Grant · Acquired 25,146 · Balance 25,146 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. F3: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2: The RSUs vested on June 2, 2026.
F3: The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Inogen Inc
Report date June 05, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 104,966 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 28,081 · Balance 104,966 F1: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were acquired pursuant to a restricted stock unit award. Subject to the reporting person's continued service, the restricted stock unit award shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant.
KESTRA MEDICAL TECHNOLOGIES, LTD.
Report date September 08, 2026 · Filed September 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 37,507 |
Reported balance
After 2026-09-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-08 · Sale · Disposed 3,908 · Balance 37,507 F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.4300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. F3: Includes 17,512 Common Shares received from West Affum Holdings, L.P., in a pro rata distribution exempt pursuant to Rule 16a-9. |
| Common SharesSEC Table I · non-derivative | Direct | 44,724 |
Reported balance
After 2026-09-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-09 · Grant · Acquired 7,217 · Balance 44,724 F4: The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $24.9100 to $25.4300. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
F3: Includes 17,512 Common Shares received from West Affum Holdings, L.P., in a pro rata distribution exempt pursuant to Rule 16a-9.
F4: The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date.
NOVANTA INC
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,897 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Exercise / conversion · Acquired 1,325 · Balance 1,897 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Exercise / conversion · Disposed 1,325 · Balance 0 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,799 |
Reported balance
After 2026-01-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-02 · Grant · Acquired 1,799 · Balance 1,799 F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares.
F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).
F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Hill-Rom Holdings, Inc.
Report date December 13, 2021 · Filed December 15, 2021
Section 16 reporting ended · disclosed 2021-12-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 1
1 source rowRow 1 · 2021-12-13 · Disposition to issuer · Disposed 2,284 · Balance 0 F1: Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $103.11 · Expires 2029-11-06 | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-13 · Disposition to issuer · Disposed 4,102 · Balance 0 F2: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $94.14 · Expires 2030-11-11 | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-13 · Disposition to issuer · Disposed 6,054 · Balance 0 F3: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock. |
| Performance-Based Restricted Stock Units (11/06/2019)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-12-13 · Disposition to issuer · Disposed 3,947 · Balance 0 F4: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F5: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level. |
| Performance-Based Restricted Stock Units (11/11/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-13 · Disposition to issuer · Disposed 4,092 · Balance 0 F4: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F6: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level. |
| Restricted Stock Units (11/06/2019)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-12-13 · Disposition to issuer · Disposed 664 · Balance 0 F7: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. |
| Restricted Stock Units (11/11/2020)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-12-13 · Disposition to issuer · Disposed 1,363 · Balance 0 F7: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock. |
| Restricted Stock Units (11/10/2021)SEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-12-13 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-12-13 · Disposition to issuer · Disposed 6,708 · Balance 0 F7: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock. F10: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Merger Agreement between Hill-Rom Holdings, Inc., Baxter International Inc. ("Baxter"), and a wholly-owned subsidiary of Baxter (the "Merger Agreement") in exchange for a cash payment of $156.00 per share of common stock.
F2: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 6, 2020, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
F3: Pursuant to the Merger Agreement, these options, which provided for vesting in four equal installments beginning on November 11, 2021, were cancelled in exchange for a cash payment representing the difference between $156.00 and the exercise price of each share of underlying common stock.
F4: Each performance-based restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F5: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 6, 2019, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 146.0% of the target performance level.
F6: Pursuant to the Merger Agreement, these performance-based restricted stock units, which were granted November 11, 2020, were cancelled in exchange for a cash payment of $156.00 per share of underlying common stock and applicable performance conditions were deemed to be achieved at 187.5% of the target performance level.
F7: Each restricted stock unit represents a contingent right to receive one share of Hill-Rom Holdings, Inc. common stock.
F8: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 7, 2020, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.
F9: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 12, 2021, were cancelled in exchange for a cash payment of $156.00 per unvested share of underlying common stock.
F10: Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal installments beginning November 11, 2022, were assumed by Baxter in the merger and converted into a number of restricted stock units granted by Baxter, that relate to shares of Baxter common stock, determined by multiplying the number of restricted stock units by the quotient obtained by dividing (A) 156.00 by (B) the average closing price, rounded down to the nearest cent, per share of Hill-Rom Holdings, Inc. common stock on the New York Stock Exchange for the consecutive period of ten (10) trading days immediately preceding (but not including) the last trading day prior to the closing date of the merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2019 Filed Nov 18, 2019 16:09 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 409 | $104.43 | $42,711.87 |
DisclosureSEC source: 0000047518-19-000099 · wf-form4_157411132839902.xml · nonDerivative · entry 2 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,268 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 16:09 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 1,185 | $104.43 | $123,749.55 |
DisclosureSEC source: 0000047518-19-000099 · wf-form4_157411132839902.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 16:14 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (11/7/2018) · Derivative | 1,960 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-19-000085 · wf-form4_157359324498007.xml · derivative · entry 3 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,806.3 Underlying: Common Stock · 1,960 shares Expires 2019-11-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 7, 2018, the reporting person was granted 5,719 restricted stock units. Restricted stock units vested 34% on 11/8/2019, 33% on 11/8/2020, and 33% on 11/8/2021. Restricted stock units are automatically converted into shares of common stock in accordance with the respective vesting schedule. Restricted stock units are entitled to dividend equivalent rights, which accrue on dividend record dates. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 16:14 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 575 | $103.73 | $59,644.75 |
DisclosureSEC source: 0000047518-19-000085 · wf-form4_157359324498007.xml · nonDerivative · entry 2 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,492 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 16:14 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 1,960 | $103.73 | $203,310.80 |
DisclosureSEC source: 0000047518-19-000085 · wf-form4_157359324498007.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 18:50 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantEmployee Stock Option (11/6/2019) · Derivative | 8,204 | $0.00 Strike: $103.11 | $0.00 |
DisclosureSEC source: 0000047518-19-000068 · wf-form4_157317061748219.xml · derivative · entry 5 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,204 Underlying: Common Stock · 8,204 shares Expires 2029-11-06 F5 · derivative.exercise_date: Options vest 25% on each of November 6, 2020, 2021, 2022 and 2023. Read SEC document |
| November 06, 2019 Filed Nov 7, 2019 18:50 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | GrantRestricted Stock Units (11/06/2019) · Derivative | 1,974 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-19-000068 · wf-form4_157317061748219.xml · derivative · entry 4 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,974 Underlying: Common Stock · 1,974 shares Expires 2022-11-07 F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: Restricted stock units vest 34% on November 7, 2020 and 33% on November 7, 2021 and 2022. Restricted stock units are entitled to dividend equivalent rights which accrue on dividend record dates. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 18:50 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionPerformance Share Units (11/14/2016) · Derivative | 3,539 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-19-000068 · wf-form4_157317061748219.xml · derivative · entry 3 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,539 shares Expires 2019-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · date: The shares of common stock were issued upon previously awarded performance based restricted stock. The performance based restricted stock unit award did not constitute derivative security reporting and therefore were not reported at the time of award. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 18:50 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 1,037 | $103.72 | $107,557.64 |
DisclosureSEC source: 0000047518-19-000068 · wf-form4_157317061748219.xml · nonDerivative · entry 2 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,107 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of performance restricted stock units in accordance with Rule 16b-3. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 18:50 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 3,539 | $103.72 | $367,065.08 |
DisclosureSEC source: 0000047518-19-000068 · wf-form4_157317061748219.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 17:06 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (7/20/2016) · Derivative | 1,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-19-004735 · marketforms-45344.xml · derivative · entry 3 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,647 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into shares of common stock on a one-for-one basis. F2 · derivative.exercise_date: On July 20, 2016, the reporting person was granted 4,845 RSUs, which vested in three equal installments on July 21, 2017, July 23, 2018 and July 22, 2019, respectively. The RSUs were automatically converted into shares of common stock on such dates and were entitled to dividend equivalent rights which accrued on dividend record dates. F2 · derivative.expiration_date: On July 20, 2016, the reporting person was granted 4,845 RSUs, which vested in three equal installments on July 21, 2017, July 23, 2018 and July 22, 2019, respectively. The RSUs were automatically converted into shares of common stock on such dates and were entitled to dividend equivalent rights which accrued on dividend record dates. Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 17:06 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 483 | $105.24 | $50,830.92 |
DisclosureSEC source: 0001214659-19-004735 · marketforms-45344.xml · nonDerivative · entry 2 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,605 Read SEC document |
| July 22, 2019 Filed Jul 24, 2019 17:06 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 1,647 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-19-004735 · marketforms-45344.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into shares of common stock on a one-for-one basis. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:13 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionRestricted Stock Units (03/05/2018) · Derivative | 1,677 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000047518-19-000015 · wf-form4_155207958705535.xml · derivative · entry 3 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,678.046 Underlying: Common Stock · 1,677 shares Expires 2020-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On 3/5/2018, the reporting person was granted 3,325 restricted stock units. Restricted stock units vested 50% on 3/6/2019 and will vest 50% on 3/6/2020. Restricted stock units are automatically converted into shares of common stock in accordance with the respective vesting schedule. Restricted stock units are entitled to dividend equivalent rights, which accrue on dividend record dates. F3 · derivative.expiration_date: On 3/5/2018, the reporting person was granted 3,325 restricted stock units. Restricted stock units vested 50% on 3/6/2019 and will vest 50% on 3/6/2020. Restricted stock units are automatically converted into shares of common stock in accordance with the respective vesting schedule. Restricted stock units are entitled to dividend equivalent rights, which accrue on dividend record dates. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:13 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Tax withholdingCommon Stock | 514 | $104.58 | $53,754.12 |
DisclosureSEC source: 0000047518-19-000015 · wf-form4_155207958705535.xml · nonDerivative · entry 2 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,441 F1 · kind: Reflects the reporting person's payment of minimum statutory tax obligations by withholding shares of Hill-Rom Holdings, Inc. Common Stock incident to the vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 16:13 UTC | Hill-Rom Holdings, Inc. HRC · Entity 132395 | Exercise / conversionCommon Stock | 1,677 | $104.58 | $175,380.66 |
DisclosureSEC source: 0000047518-19-000015 · wf-form4_155207958705535.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · SVP, Corp. Dev., Strat. & IR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.